T

Takayuki Yoshino

University of Tsukuba

ORCID: 0000-0002-0489-4756

Publishes on Colorectal Cancer Treatments and Studies, Gastric Cancer Management and Outcomes, Cancer Genomics and Diagnostics. 1.6k papers and 51.5k citations.

PubIndex Score98Top 2%How it's scored

1.6kPublications

51.5kTotal Citations

First publication: 1966First senior author: 1986

Colorectal Cancer Treatments and Studies Gastric Cancer Management and Outcomes Cancer Genomics and Diagnostics Genetic factors in colorectal cancer Cancer Treatment and Pharmacology

Top publicationsby citations

Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2016 for the treatment of colorectal cancer

Kenichi Sugihara, Toshiaki Watanabe, Kei Muro et al.|International Journal of Clinical Oncology|2017

Cited by 2.5k

Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2019 for the treatment of colorectal cancer

Yojiro Hashiguchi, Kei Muro, Yutaka Saitō et al.|International Journal of Clinical Oncology|2019

Cited by 2k

Encorafenib, Binimetinib, and Cetuximab in <i>BRAF</i> V600E–Mutated Colorectal Cancer

Scott Kopetz, Josep Tabernero, Axel Grothey et al.|New England Journal of Medicine|2019

Cited by 1.5k

Localised colon cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Guillem Argilés, Dirk Arnold, Josep Tabernero et al.|Annals of Oncology|2020

Cited by 1.3k

Ramucirumab versus placebo in combination with second-line FOLFIRI in patients with metastatic colorectal carcinoma that progressed during or after first-line therapy with bevacizumab, oxaliplatin, and a fluoropyrimidine (RAISE): a randomised, double-blind, multicentre, phase 3 study

Josep Tabernero, Federico Nasroulah, Takayuki Yoshino et al.|The Lancet Oncology|2015

Cited by 954